companies chevron-corp 
Patently-O
OCTOBER 27, 2021
Chevron Oronite Company LLC , No. Lotte International America Corp. , Janssen Pharmaceutica, N.V. , 21-202 ( NHK-Fintiv rule for denying petitions; appealability of IPR petition denial); Apple Inc. Optis Cellular Technology, LLC , No. 21-118 (mandamus review of IPR petition denial); Infineum USA L.P. Bongiorno v.
Fish & Richardson Trademark & Copyright Thoughts
JANUARY 11, 2022
Several other companies have also announced plans to pursue interchangeable status for biosimilar products. Consistent with this, as shown below in Table 2, numerous companies have publicly announced the submission and/or acceptance of new biosimilar BLAs. Stimufend ® (Fresenius Kabi). Neulasta ® (Amgen). pegfilgrastim.
Expert insights. Personalized for you.
78 
Let's personalize your content